Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.8B
sum of reported positions
Reported positions
100
Changes vs prior quarter
140
64 new · 46 exited
Filings on record
7
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024
Across 163 measured positions in 6 quarters, the typical new or larger position finished −0.2 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 2.1M | $393M | 6.8% | |
| 1.33M | $317M | 5.5% | |
VANECK GOLD MINERS ETF | 3.55M | $268M | 4.6% |
| 110K | $250M | 4.3% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.24B | $5.8B |
| Positions | 82 | 100 |
| Biggest line | — | Revolution Medicines 7% |
| 388K | $225M | 3.9% |
| 9.46M | $200M | 3.4% |
| 528K | $189M | 3.3% |
| 854K | $171M | 2.9% |
| 2.18M | $157M | 2.7% |
| 420K | $157M | 2.7% |
| 332K | $140M | 2.4% |
| 1.16M | $134M | 2.3% |
ISHARES MSCI BRAZIL ETF | 3.7M | $128M | 2.2% |
| 438K | $127M | 2.2% |
| 280K | $125M | 2.2% |
ISHARES CHINA LARGE CAP ETF | 3.88M | $122M | 2.1% |
ISHARES CORE MSCI EMERGING ETF | 1.25M | $104M | 1.8% |
| 295K | $87.9M | 1.5% |
| 1.25M | $84.2M | 1.5% |
| 2.88M | $82.3M | 1.4% |
| 349K | $78M | 1.3% |
| 1.77M | $77.7M | 1.3% |
| 349K | $77M | 1.3% |
| 362K | $72.7M | 1.3% |
| 340K | $71.1M | 1.2% |
ST STR SPDR POR DE WO EX US ETF
6.04M shares in Q1 2026
KRANESHARES CSI CHINA INTERNET ETF
2.38M shares in Q1 2026
VANGUARD FTSE DEVELOPED MARKETS ETF
2.23M shares in Q1 2026
TERNS PHARMACEUTICALS ORD
2.15M shares in Q1 2026
ISHARES CORE MSCI TOTL INTL STCK ETF
1.41M shares in Q1 2026
Wells Fargo (WFC)
1M shares in Q1 2026
Hess Midstream LP (HESM)
900K shares in Q1 2026
VANGUARD FTSE PACIFIC ETF
788K shares in Q1 2026
ONESTREAM CL A ORD
708K shares in Q1 2026
Newmont (NEM)
702K shares in Q1 2026
NEOS NASDAQ 100 HIGH INCOME ETF
700K shares in Q1 2026
Procter & Gamble (PG)
435K shares in Q1 2026
Abbott Laboratories (ABT)
425K shares in Q1 2026
Johnson & Johnson (JNJ)
370K shares in Q1 2026
ISHARES TOTAL US STOCK MARKET ETF
310K shares in Q1 2026
Broadcom (AVGO)
301K shares in Q1 2026
Insmed (INSM)
300K shares in Q1 2026
Chevron (CVX)
251K shares in Q1 2026
Qfin Holdings (QFIN)
250K shares in Q1 2026
SCHWAB FUNDAMNTL INTRNL EQT ETF
214K shares in Q1 2026
Gilead Sciences (GILD)
200K shares in Q1 2026
PBF Energy (PBF)
200K shares in Q1 2026
J.M. Smucker Company (The) (SJM)
200K shares in Q1 2026
ISHARES ESG AWARE MSCI EM ETF
200K shares in Q1 2026
American Tower (AMT)
190K shares in Q1 2026
